Regenerative Medicine Production System with Dynamic Parameter Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
It is challenging to produce regenerative medicine products with uniform performance and quality, especially when scaling from research to commercial production, due to individual differences in cells or tissues and environmental changes during transport, making it difficult to apply a Quality-by-Design (QbD) approach effectively.
Innovation Solution
A production system comprising a production device that analyzes starting materials and a central management device that determines processing conditions, allowing for on-site production near the patient and reducing environmental impact, with data transmission to optimize processing conditions based on the material's performance and quality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If mass production of regenerative medicine products is implemented, then productivity increases, but uniformity of starting material performance and quality deteriorates
Solution Approach 1:
The patent applies local quality by customizing processing conditions for each starting material batch based on its specific characteristics. Instead of using uniform processing parameters for all materials, the system adjusts conditions (such as temperature, time, and other parameters) according to the individual properties of each starting material, thereby maintaining high uniformity even during mass production
Solution Approach 2:
The system dynamically changes processing parameters based on the analyzed characteristics of each starting material. By modifying parameters such as processing temperature, duration, and other conditions according to the specific properties of the starting material, the patent achieves both high productivity and consistent product quality across large production volumes
2Quantity of substance
If starting material is collected from multiple donors, then quantity of starting material increases, but uniformity of performance and quality deteriorates
Solution Approach 1:
The patent applies local quality by customizing processing conditions for each starting material batch based on its specific characteristics. Instead of using uniform processing parameters for all materials, the system adjusts conditions (such as temperature, time, and other parameters) according to the individual properties of each starting material, thereby maintaining high uniformity even during mass production
Solution Approach 2:
The system performs preliminary analysis of starting materials to characterize their properties before processing. By analyzing and understanding the specific characteristics of each starting material in advance, the system can pre-determine optimal processing conditions, ensuring uniformity is maintained even when collecting materials from multiple donors
3Ease of manufacture
If production conditions are standardized, then ease of manufacture improves, but adaptability to individual starting material differences deteriorates
Solution Approach 1:
The patent applies dynamics by making processing conditions adjustable rather than fixed. The system incorporates dynamic parameter adjustment capabilities that allow processing conditions to be modified in real-time based on the specific characteristics of the starting material, combining the simplicity of standardized processes with the flexibility to adapt to individual material differences
Solution Approach 2:
The system implements feedback mechanisms that monitor and analyze starting material characteristics, then use this information to automatically adjust processing conditions. This feedback loop enables the system to maintain ease of manufacture while adapting to individual starting material differences through data-driven parameter optimization
Data Source
AI summary
Production of “regenerative medicine products” is facilitated using a quality by design (QbD) approach. A production device produces a medical product and analyzes a starting material and a central management device determines processing conditions in the production device. By transmitting and receiving data pertaining to the starting material between the production device and central management device data, the medical product is produced while production conditions therefor are continuously optimized. Thus, it is easy to produce a medical product while reducing or eliminating effects from changes in cells and tissues over time, from oscillation during transport, and from changes in surrounding environment such as changes in temperature, and to produce the desired medical product even when there are individual differences in the starting material.